Phillips 66 · PSX · FY2026 Q1 · Calendar Q2 2026
PSX Q1 2026: EPS Beat Amid $839M MTM Loss, 138% Market Capture Sustains Cash Flow
Phillips 66 reported Q1 2026 adjusted earnings of $200 million (EPS of $0.49), sharply beating consensus estimates of a $0.54 loss, as a 138% market-capture rate leveraged global refining disruptions from Middle East tensions. Revenue of $33.0 billion fell approximately 8% below estimates. The quarter was dominated by an $839 million mark-to-market loss on hedge positions, yet the company generated $700 million in operating cash flow, returned $778 million to shareholders, and maintained its commitment to return over 50% of cash flow while reducing debt toward $17 billion by 2027. The stock rose 5.1% on the print with an additional 1.9% subsequent drift. Management pointed to the Western Gateway pipeline FID in mid-to-late summer 2026 (a Kinder Morgan joint venture), doubled renewable diesel RIN credits year-over-year, and CPChem growth projects (Golden Triangle polymers, RPP Qatar)…
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about PSX FY2026 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared to Q4 2025 — where the narrative centered on the WRB acquisition, cost reductions toward $5.50/barrel by 2027, and a $1 billion midstream EBITDA run-rate — Q1 2026 introduced several new dynamics. An $839 million mark-to-market loss on hedges, driven by Middle East tensions and commodity price swings, became the dominant headline item, though partially offset by $3.2 billion in margin collateral (since declined to $2.1 billion). The 138% market-capture rate was a standout, reflecting the commercial team's ability to exploit arbitrage opportunities during global refinery disruptions. Western Gateway pipeline progressed from conceptual to a Kinder Morgan JV with FID targeted mid-to-late summer 2026 and service by 2029. Renewable diesel RIN credits more than doubled year-over-year, a potential free-cash-flow inflection point. Debt reduction targets were specified more precisely: $19 billion by year-end 2026 and $17 billion by 2027. Capex outlook shifted from increasing to stable.
Guidance delta
Guidance was maintained overall. Capex outlook moved from increasing (Q4 2025) to stable (Q1 2026). The $2.4 billion annual capital program target from Q4 2025 was not contradicted. Debt reduction targets were refined to $19 billion by year-end 2026 and $17 billion by 2027. The over-50% cash-flow return to shareholders commitment was reaffirmed. Western Gateway pipeline FID was targeted for mid-to-late summer 2026 with a Kinder Morgan JV and 2029 service start. The midstream EBITDA goal of $4.5 billion by 2027 (stated in Q4 2025) was not explicitly updated but was not walked back.
Key takeaways
- EPS of $0.49 beat consensus of -$0.54 by 190%, driven by a 138% market-capture rate exploiting global refining disruptions.
- Revenue of $33.0B missed estimates by approximately 8%, reflecting lower realized prices despite strong volumes.
- An $839M mark-to-market loss on hedges masked underlying cash generation of $700M and $778M returned to shareholders.
- Western Gateway pipeline advanced to a Kinder Morgan JV with FID targeted mid-to-late summer 2026 and service by 2029.
- Renewable diesel RIN credits more than doubled year-over-year, potentially driving a material free-cash-flow inflection.
- Debt reduction targets refined to $19B by year-end 2026 and $17B by 2027, with capex outlook stable.
Management priorities
- Return over 50% of operating cash flow to shareholders via dividends, buybacks, and debt reduction.
- Reduce debt to $19B by year-end 2026 and $17B by 2027.
- Finalize Western Gateway pipeline JV and reach FID by mid-to-late summer 2026.
- Commission Golden Triangle polymers project in 2026 and RPP project in Qatar by 2027.
- Expand renewable diesel capacity and leverage higher RIN values.
- Maintain midstream gathering and processing investment to support NGL volume growth.
Follow PSX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 22, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 14, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 13, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 12, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 12, 2026 |
| Mizuho | Neutral | Outperform | Downgrade | Oct 8, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 1, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 17, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Sep 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 14, 2026 |
| UBS | Buy | Buy | Maintain | Sep 8, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Sep 3, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 9, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Apr 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 13, 2026 |
| Freedom Capital Markets | Sell | Hold | Downgrade | Jan 6, 2026 |
| Freedom Broker | Sell | Hold | Downgrade | Jan 6, 2026 |
| B of A Securities | Neutral | Buy | Downgrade | Sep 3, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 3, 2025 |
| Argus Research | Buy | Buy | Maintain | May 30, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | May 4, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Dec 28, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | May 12, 2021 |
| CFRA | Buy | Buy | Maintain | Mar 20, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Jan 7, 2020 |
| Macquarie | Outperform | Outperform | Maintain | Sep 5, 2019 |
| U.S. Capital Advisors | Buy | Overweight | Maintain | Nov 16, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 19, 2018 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Sep 28, 2017 |
| PiperJaffray | Neutral | Neutral | Maintain | Sep 16, 2016 |
| Oppenheimer | Outperform | Perform | Upgrade | May 27, 2015 |
| Gilford Securities | Neutral | Buy | Downgrade | Mar 31, 2015 |
| Tudor Pickering | Accumulate | Buy | Maintain | Apr 15, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $268.53. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Analyst unavailable | $335 | $293.81 | +24.8% | Oct 19, 2026 |
| Wells Fargo | Sam Margolin | $345 | $292.73 | +28.5% | Oct 14, 2026 |
| Jefferies | Analyst unavailable | $276 | $278.18 | +2.8% | Oct 11, 2026 |
| Mizuho Securities | Nitin Kumar | $300 | $271.62 | +11.7% | Oct 8, 2026 |
| Goldman Sachs | Neil Mehta | $274 | $255.31 | +2.0% | Oct 1, 2026 |
| BMO Capital | Analyst unavailable | $310 | $264.63 | +15.4% | Sep 17, 2026 |
| Raymond James | Analyst unavailable | $300 | $261.61 | +11.7% | Sep 14, 2026 |
| Morgan Stanley | Analyst unavailable | $284 | $263.86 | +5.8% | Sep 14, 2026 |
| UBS | Manav Gupta | $300 | $255.09 | +11.7% | Sep 8, 2026 |
| Piper Sandler | Analyst unavailable | $264 | $256.09 | -1.7% | Sep 3, 2026 |
| Wells Fargo | Analyst unavailable | $335 | $246.58 | +24.8% | Sep 1, 2026 |
| Piper Sandler | John Royall | $209 | $203.91 | -22.2% | Aug 10, 2026 |
| Wells Fargo | Sam Margolin | $239 | $202.55 | -11.0% | Aug 6, 2026 |
| Barclays | Theresa Chen | $216 | $202.55 | -19.6% | Aug 6, 2026 |
| UBS | Manav Gupta | $235 | $205.78 | -12.5% | Jul 27, 2026 |
| Piper Sandler | Analyst unavailable | $208 | $211.41 | -22.5% | Jul 23, 2026 |
| Goldman Sachs | Neil Mehta | $235 | $212.27 | -12.5% | Jul 22, 2026 |
| Raymond James | Analyst unavailable | $235 | $194.4 | -12.5% | Jul 13, 2026 |
| Jefferies | Analyst unavailable | $207 | $189.64 | -22.9% | Jul 9, 2026 |
| Barclays | Analyst unavailable | $183 | $188.68 | -31.9% | Jul 9, 2026 |
| UBS | Manav Gupta | $212 | $173.71 | -21.1% | Jun 15, 2026 |
| Morgan Stanley | Joe Laetsch | $196 | $178.1 | -27.0% | Jun 12, 2026 |
| Mizuho Securities | Nitin Kumar | $212 | $173.88 | -21.1% | May 27, 2026 |
| Goldman Sachs | Analyst unavailable | $207 | $182.38 | -22.9% | May 19, 2026 |
| Morgan Stanley | Analyst unavailable | $180 | $175.72 | -33.0% | Apr 30, 2026 |
| Morgan Stanley | Analyst unavailable | $174 | $159.53 | -35.2% | Apr 24, 2026 |
| Piper Sandler | Ryan Todd | $177 | $168 | -34.1% | Apr 8, 2026 |
| Barclays | Analyst unavailable | $158 | $155.41 | -41.2% | Feb 20, 2026 |
| Jefferies | Analyst unavailable | $158 | $155.41 | -41.2% | Feb 20, 2026 |
| UBS | Analyst unavailable | $172 | $158.31 | -35.9% | Feb 6, 2026 |
| BMO Capital | Phillip Jungwirth | $170 | $158.38 | -36.7% | Feb 6, 2026 |
| Morgan Stanley | Analyst unavailable | $147 | $154.69 | -45.3% | Feb 5, 2026 |
| Piper Sandler | Analyst unavailable | $156 | $154.69 | -41.9% | Feb 5, 2026 |
| Scotiabank | Paul Cheng | $140 | $140.08 | -47.9% | Jan 16, 2026 |
| Mizuho Securities | Analyst unavailable | $152 | $138.8 | -43.4% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $142 | $142.16 | -47.1% | Jan 12, 2026 |
| Piper Sandler | Analyst unavailable | $153 | $142.16 | -43.0% | Jan 12, 2026 |
| Mizuho Securities | Analyst unavailable | $150 | $143.37 | -44.1% | Dec 12, 2025 |
| Piper Sandler | Analyst unavailable | $171 | $139.42 | -36.3% | Dec 5, 2025 |
| UBS | Manav Gupta | $160 | $138.4 | -40.4% | Nov 10, 2025 |
| Piper Sandler | Analyst unavailable | $159 | $138 | -40.8% | Oct 30, 2025 |
| Wells Fargo | Analyst unavailable | $162 | $138 | -39.7% | Oct 30, 2025 |
| Raymond James | Analyst unavailable | $150 | $129.13 | -44.1% | Oct 17, 2025 |
| Barclays | Analyst unavailable | $132 | $132.92 | -50.8% | Oct 7, 2025 |
| Morgan Stanley | Analyst unavailable | $140 | $134.94 | -47.9% | Oct 3, 2025 |
| Piper Sandler | Ryan Todd | $155 | $139.46 | -42.3% | Sep 29, 2025 |
| Raymond James | Analyst unavailable | $145 | $132.29 | -46.0% | Sep 9, 2025 |
| Morgan Stanley | Joe Laetsch | $128 | $127.51 | -52.3% | Jul 16, 2025 |
| Raymond James | Justin Jenkins | $142 | $129.01 | -47.1% | Jul 15, 2025 |
| Scotiabank | Paul Cheng | $133 | $131.71 | -50.5% | Jul 11, 2025 |
| Piper Sandler | Ryan Todd | $148 | $134.39 | -44.9% | Jul 10, 2025 |
| Cantor Fitzgerald | Matthew Prisco | $55 | $124.82 | -79.5% | Jun 18, 2025 |
| Goldman Sachs | Analyst unavailable | $132 | $124.72 | -50.8% | Mar 27, 2025 |
| Mizuho Securities | Nitin Kumar | $140 | $115.19 | -47.9% | Jan 13, 2025 |
| Barclays | Theresa Chen | $115 | $115.19 | -57.2% | Jan 13, 2025 |
| Piper Sandler | Ryan Todd | $144 | $132.31 | -46.4% | Oct 17, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $156 | $132.31 | -41.9% | Oct 17, 2024 |
| Mizuho Securities | Nitin Kumar | $160 | $135.85 | -40.4% | Jun 20, 2024 |
| Piper Sandler | Ryan Todd | $170 | $143.66 | -36.7% | May 14, 2024 |
| Mizuho Securities | Nitin Kumar | $162 | $165.41 | -39.7% | Apr 12, 2024 |
| Wells Fargo | Roger Read | $179 | $170.75 | -33.3% | Apr 8, 2024 |
| Piper Sandler | Ryan Todd | $187 | $170.68 | -30.4% | Apr 5, 2024 |
| Raymond James | Justin Jenkins | $140 | $133.21 | -47.9% | Jan 10, 2024 |
| RBC Capital | Analyst unavailable | $132 | $102.06 | -50.8% | Feb 8, 2023 |
| Raymond James | Analyst unavailable | $135 | $102.09 | -49.7% | Jan 13, 2023 |
| Wells Fargo | Analyst unavailable | $127 | $102.18 | -52.7% | Jan 5, 2023 |
| Piper Sandler | Analyst unavailable | $137 | $100.64 | -49.0% | Dec 19, 2022 |
| Raymond James | John Freeman | $48 | $102.07 | -82.1% | Dec 13, 2022 |
| RBC Capital | Analyst unavailable | $131 | $106.24 | -51.2% | Nov 10, 2022 |
| Goldman Sachs | Neil Mehta | $109 | $90.51 | -59.4% | Jun 21, 2022 |
| RBC Capital | Analyst unavailable | $106 | $89.94 | -60.5% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $114 | $86.76 | -57.5% | May 2, 2022 |
| Raymond James | Analyst unavailable | $107 | $86.76 | -60.2% | May 2, 2022 |
| Wells Fargo | Analyst unavailable | $103 | $88.87 | -61.6% | Apr 21, 2022 |
| Piper Sandler | Ryan Todd | $119 | $87.16 | -55.7% | Apr 18, 2022 |
| Cowen & Co. | Jason Gabelman | $78 | $73.15 | -71.0% | Dec 28, 2021 |
| Bank of America Securities | Doug Leggate | $102 | $80.95 | -62.0% | Oct 19, 2021 |
| Citigroup | Prashant Rao | $80 | $76.66 | -70.2% | Oct 6, 2021 |
| Credit Suisse | Manav Gupta | $95 | $81.54 | -64.6% | May 12, 2021 |
Track every rating change on PSX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPhillips 66 operates as a diversified energy company, specializing in both manufacturing and logistics. Its comprehensive business model is structured across four primary segments: Midstream, Chemicals, Refining, and Marketing & Specialties (M&S). The Midstream division manages the vital infrastructure for transporting and processing various energy commodities. This includes moving crude oil and other feedstocks, delivering refined petroleum products to market, offering terminaling and storage solutions, and handling natural gas liquids (NGLs) through processes like transportation, storage, fractionation, export, and marketing. It also provides fee-based processing services and oversees the gathering, processing, transportation, and marketing of natural gas. The Chemicals segment is dedicated to the production and distribution of a broad spectrum of chemical products.…
Historical context
All PSX earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SLB Slb N.V. | FY2026 Q3 · Calendar Q4 2026 | +3.7% | +7.1% | SLB Q3 2026: Growth Broadens Beyond Core Oilfield |
| E Eni S.p.A. | FY2026 Q3 · Calendar Q4 2026 | +13.9% | +4.3% | Eni pairs upstream growth with record shareholder returns and transition progress |
Latest beats and misses
Who reports nextBeat on EPS
- CINFFY2026 Q3 · October 26, 2026+39.5% EPS+2.3% move
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
- BAHFY2027 Q2 · October 23, 2026+18.9% EPS-0.3% move
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
Missed on EPS
- SUIFY2026 Q3 · October 26, 2026-20.0% EPS-4.1% move
- PSA-PIFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PJFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PHFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PFFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PSFY2026 Q3 · October 26, 2026-32.1% EPS— move
Get the PSX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-29T08:02:43.552529+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T08:02:43.549664+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-07-29. For educational purposes only; not investment advice.